chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was instructed to wait 30 minutes, but left after 15 minutes, returned to clinic with c/o squeezing in the throat and neck. Was red and hot in appearance. Emergency was called, epi and diphenhydramine was administered.  Transported via ambulance to local ER, was able to ambulate to transport vehicle.
My arm from the elbow to the shoulder is hard, red and very itchy. I am having some sort of allergic reaction. My armpit hurts as well so, i think my lymph nodes are enlarged.
Breakthrough case admission after three vaccines Pfizer 3/23/21 Lot# EN6207;  Pfizer 4/13/21 Lot# EW0150;  Pfizer 8/5/22 Lot# FN2908
On 11-8-13 pt received FLUZONE HD and PNEUMOVAX 23 in left deltoid. That evening while stretching hand (extending fingers then making a fist) developed trigger finger (ring finger left hand). Something she had never noticed before. Reported arm was really sore for days (2).
Fever. If this continues I will take him to doctors or ER. Im calling in sick from work.
Chronic urticaria Patient developed symptoms for 2 weeks,  before visiting allergist. Patient had to take daily zyryec for relief for over 5 months. Patient still has nightly courses of urticaria, though improving.
Pt recvd 1st dose of Hep B in approx JUN91; approx 10 to 14 days later devel low grade fever of 100 w/joint pain, primarily pts in knees & elbows; also exp malaise & pruritis;
Painful arm,  with red itchy rash appearing  on 3rd day from vaccination.  Covid Arm
One hour post vax, child became lethargic, slight temperature of 100. Didn't eat and seemed to drool a little more than usual. About 11:00 PM, had seizure. Taken to ER. Had fever for 9 days following of 100 - 102.  Please note that 2 days post 3 dose of DTaP, pt experienced seizure but didn't inform nurse at time of 4th vax. At that time, the physician did not feel it was a result of vax.
Sore in left shoulder area. Left shoulder area achy at rest and severe pain when mobilizing.
Delayed hypersensitivity reaction; About 5 to 8 cm diameter pruritus around the injection site; About 5 to 8 cm diameter redness around the injection site; About 5 to 8 cm diameter swelling around the injection site; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed hypersensitivity reaction), VACCINATION SITE PRURITUS (About 5 to 8 cm diameter pruritus around the injection site), VACCINATION SITE ERYTHEMA (About 5 to 8 cm diameter redness around the injection site) and VACCINATION SITE SWELLING (About 5 to 8 cm diameter swelling around the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed hypersensitivity reaction), VACCINATION SITE PRURITUS (About 5 to 8 cm diameter pruritus around the injection site), VACCINATION SITE ERYTHEMA (About 5 to 8 cm diameter redness around the injection site) and VACCINATION SITE SWELLING (About 5 to 8 cm diameter swelling around the injection site). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed hypersensitivity reaction), VACCINATION SITE PRURITUS (About 5 to 8 cm diameter pruritus around the injection site), VACCINATION SITE ERYTHEMA (About 5 to 8 cm diameter redness around the injection site) and VACCINATION SITE SWELLING (About 5 to 8 cm diameter swelling around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported This was reported by a physician,  who wrote 12 men experienced an 8th day delayed hypersensitivity reaction to the first shot of Moderna COVID vaccine(about 5 to 8 cm diameter redness, swelling and pruritus around the injection site which lasts 4 days to a week).
This initial spontaneous report was received from a licensed practical nurse (LPN) via a Company representative and refers to a 21 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. The patient died in 2008 after receiving her third dose of GARDASIL (lot # not provided) (also reported that the patient died an unspecified time after receiving the third dose in 2008). Dates of the three doses were not provided.  Cause of death was not specified. The LPN said that patients at the office were asking questions about the event/incident because there have been multiple online posts being made about the event (also reported as reports of the death are being circulated on the internet). The Company employee stated that the "lawsuit just got settled" so that is why people were asking about it again. The LPN asked the Company employee what the Company had to say about the incident. Causality was not specified. Upon internal review, death was considered to be medically significant. The LPN did not want to be contacted for follow-up.; Reported Cause(s) of Death: died.
Chills, fever, muscle aches, joint aches, nausea, and headache lasting 24 hours. Pain at injection site, red rash at injection site and induration at injection site lasting more than 48 hours.
Nine Days after my injection, flu like symptoms, (I never get sick) worst Nasal Congestion, then worst throat drip almost like a poison, had trouble breathing, worst headache ever in my life on the 12th day, I never get headaches, by the 15th day I felt a little better. I had more nasal and throat mucus in the last 2 weeks than most of my life time. I will think long and hard before I consider another Flu Shot.    I understand in is an Inactive Virus, I  "BEG TO DIFFER" ,  I work in a home office and was not near any customers for 95% of the 9 Days after my Injection. I felt somewhat better 12/23/2019.
Patient received seasonal high-dose influenza vaccine on 10/23/18. On 10/31/18 patient presented to the Hospital Emergency Department due to diarrhea and 1-2 days history of ataxic gait. Patient was ultimately diagnosed by neurology via phone consult with post viral cerebellitis but given recent flu vaccine cannot R/O vaccine as cause to symptoms. Patient was then seen in our office 11/2/18 with noted improvement in ataxic gait but still with some ataxia. Patient otherwise well-appearing with non-focal neurologic exam.
Left thigh red and itchy from shots cellulitis, warm soaks, Cefzil, F/U in 2 days.
Information has been received from a consumer concerning a friend's child who was vaccinated with a dose of MMR and became autistic. Unspecified medical attention was sought. There was no product quality complaint involved. Upon internal review autistic was considered to be an other important medical event (OMIC). Additional information has been requested.
Severe fatigue and body aches. Severe difficulty to urinate, even after having taken both Cialis and Flomax, which normally would restore normal urinary function. This lasted about two days. It is less severe in the third day.
10/26/2021 Tingling on face and lips that caused me to go to the doctors. It was only on the right side of face and I did not want to get an MRI right away. It has progressed to both side of my face and fingers. Exercise tolerance has become terrible and have been needing to use my oxygen more. I did have a CT of head and neck that showed no issues. I am having dizziness accompanying everything else. Respiratory therapist was doing well however my blood pressure was too low and drops while I exercise and was told to meet with the cardiologist. I have been taking Gabapentin for nerve pain and had stopped due to vertigo I was experiencing.
A registered nurse reported that a 2 month old male received Prevnar vaccine and subsequently developed fever, irritability, inconsolable crying and was not eating. No additional info was available as of the date of this report.
tested positive for COVID; Tested positive for Covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program, COVAX support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 12Feb2021 (lot number was not reported), as 2nd dose, single dose, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received the 2nd dose of COVID-19 vaccine on 12Feb2021 and tested positive for COVID on 09May2021 (reported as "this past Sunday"). Treatment included antibody infusion which the patient received on 11May2021. The outcome of the event was unknown.  Information related to batch/lot no. was requested.
Patient was found unresponsive in her crib at 6:45 AM when her motion sensitive baby monitor sounded on alarm. CRP was performed; EMT arrived. Patient was transported to hospital where she was DOA. Autopsy Report received on 12/22/2004 states SIDS. Discharge Summary received on 1/7/2005 states apnea and asystole.
This is a spontaneous report from a contactable consumer. A female patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration, in Oct2016 at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient was vaccinated in Oct2016 and she cannot move her arm very well, and has a little pain on it on an unspecified date. Outcome of the events was unknown.
Pt. received vaccine on 6/16/2003 and on 6/21/2003 experienced chest pain. She had Mexican food on 6/20 and thought this, ie hearburn, was the cause of her chest pain. She works in a lab and had a CPK done which she reported was normal. She did not see a doctor and did not have any further studies. Pain resolved that day and did not reccur.
Red, raised rash noted over bilateral arms, legs, one on face and two on torso with itchiness associated with rash. Also red, swollen and warmth noted at injection site. Rash started around 9am on 8/9/18 on legs then arms the face and torso. After seeing employee health, employee had taken Benadryl for the itchiness and was excused from work until signs and symptoms resolved. Employee states she is very sensitive to vaccines on the past hence why several months between doses were given and that she was not feeling well in July.
Pain down arm to elbow, tingling in 3 fingers on Lt hand. (Pain started 2 days after injection) (tingling started on 9/15/11 - 8 days after injection).
slight reaction that lasted about 2 weeks; area was itchy/On occasion, left arm feels itchy intermittently; she developed a rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (slight reaction that lasted about 2 weeks), VACCINATION SITE PRURITUS (area was itchy/On occasion, left arm feels itchy intermittently) and RASH (she developed a rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 017B21A and 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for Blood pressure, ROSUVASTATIN for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced VACCINATION COMPLICATION (slight reaction that lasted about 2 weeks), VACCINATION SITE PRURITUS (area was itchy/On occasion, left arm feels itchy intermittently) and RASH (she developed a rash). The patient was treated with CORTISONE for Adverse event, at a dose of UNK (Cortisone 10). In December 2021, VACCINATION COMPLICATION (slight reaction that lasted about 2 weeks) had resolved. At the time of the report, VACCINATION SITE PRURITUS (area was itchy/On occasion, left arm feels itchy intermittently) had not resolved and RASH (she developed a rash) outcome was unknown.            Patient states when it itches Patient looks at it and nothing there but in the same area.   This case was linked to MOD-2022-458783, MOD-2022-458708 (Patient Link).
Tired, headache, high fever 104.6 Arm sore back sore, coughing labored breathing
administered 8 doses of Vaccine 2 days after the vaccine expired; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 8 doses of Vaccine 2 days after the vaccine expired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 8 doses of Vaccine 2 days after the vaccine expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 8 doses of Vaccine 2 days after the vaccine expired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatments were reported.
shingles; Information has been received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2018, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) as prescribed and/or administered by a healthcare provider for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date (reported as subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation), the patient was treated by a healthcare provider for shingles (herpes zoster). On an unknown date, the patient was admitted to the hospital due to the event. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. At the time of this report, the outcome of herpes zoster was unknown. The lawyer considered the event to be related to zoster vaccine live (ZOSTAVAX).
Started with rash around eyes, around nose to upper lip just below nose.  Swelling to my lower eye lids began saturday 11/07/2009.  I used Benadryl 25mg PO for the reaction.  Then I used hydrocortisone cream to aleviate itchyness.  Swelling continued sunday and was worse Monday today.  Itchyness has diminished however the swelling around my eyes appear worse.
Woke up day after, chills, sweats, malaise, fatigue, large erythematous area around injection site extending to medial bicep area
High fever, chills, splitting headache,  muscle aches, tiredness, cold sweat, congestion.  Treatment: Lots of water, rest, and Tylenol
One day post vax, the pt experienced hives all over the body. The pt was treated with Zyrtec. The pt also had trouble swallowing. Following that the pt was then given Prednisolone.
Per note in computer nurse whom saw client: "Shoulder area above right deltoid is swollen and warm to touch and painful to touch".
Sclerouveitis of the left eye/ Uveitis; nodular scleritis; annular elastolytic giant cell granuloma of conjuctiva; Granulomatous dermatitis with elastophagotosys multinucleated/ Elastolytic granuloma; Allergic rhinoconjunctivitis; Allergic rhinitis; Periorbital darkening of the skin; Joint pain; Back pain; positive ANA; ocular inflammation; This case was reported by a consumer and described the occurrence of uveitis in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included asthma.   On an unknown date, the patient received Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced uveitis (serious criteria GSK medically significant), scleritis (serious criteria GSK medically significant), conjunctival granuloma (serious criteria GSK medically significant), granulomatous dermatitis, allergic rhinoconjunctivitis, allergic rhinitis, dark circles under eyes, joint pain, back pain, antinuclear antibody positive and eye inflammation. On an unknown date, the outcome of the uveitis, scleritis, conjunctival granuloma, granulomatous dermatitis, allergic rhinoconjunctivitis, allergic rhinitis, dark circles under eyes, joint pain, back pain, antinuclear antibody positive and eye inflammation were unknown.   It was unknown if the reporter considered the uveitis, scleritis, conjunctival granuloma, granulomatous dermatitis, allergic rhinoconjunctivitis, allergic rhinitis, dark circles under eyes, joint pain, back pain, antinuclear antibody positive and eye inflammation to be related to Shingrix.  Additional details were provided as follows: The case was reported by the daughter of the patient. The age at vaccination was not reported. The reporter stated that the patient had same problem that she had 2 weeks after the shot. The reporter on her skin (right temple) had granulomatous dermatitis with elastophagotosys multinucleated giant cells and intermixed lymphocytes, annular elastolytic giant cell granuloma of conjunctiva. The reporter was diagnosed with uveitis, sclerouveitis, allergic rhinitis. The reporter also had complaint of dark circles under eyes, ocular inflammation, joint and back pain, there was a nodular scleritis, positive ANA (antinuclear antibody), allergic rhinoconjunctivitis. This is 1 of the 3 link cases, reported by same reporter. Note: The reporter stated that the patient had same problem that she had, however did not exactly mention the events experienced by the patient. Hence all the major diagnosis/events of the reporter was added in this case.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR092345:Reporter's case US-GLAXOSMITHKLINE-US2021AMR102602:same reporter / drug/ US-GLAXOSMITHKLINE-US2021AMR102632:Same reporter
Pt received injections and was sitting on the table, I turned around to talk with mom ,asked her if she needed anything ,and then the mom started screaming stating pt was having a seizure, the next thing pt was on the floor, I ran to pt and asked mom to go get a doctor, pt was laughing and talking right after I gave shots.
On the first day, Fever 103  General body aches On the second day after the vaccine, extreme in the right leg, especially the hip and back of the thigh  The pain is persisting and extreme difficulty walking  I have been taking Pregabalin 75 mg and also acyclovir for possible shingles outbreak  I saw a pain doctor, who administered an injection of steroid and novocain on March 10
injection site pain - pain in right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 4-year-old male patient received BNT162b2 (COMIRNATY), on 22Jun2022 at 17:15 as dose 1, single (Lot number: FT9142) at the age of 4 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing); "known allergis: Tree nuts" (unspecified if ongoing), notes: known allergies: Tree Nuts, Eggs; "known allergis: Eggs" (unspecified if ongoing), notes: known allergies: Tree Nuts, Eggs; "Covid-19" (unspecified if ongoing), notes: If Covid prior vaccination: Yes. Concomitant medication(s) included: CHILDREN'S ZYRTEC. The following information was reported: INJECTION SITE PAIN (non-serious) with onset 22Jun2022 at 20:30, outcome "recovered" (Jun2022), described as "injection site pain - pain in right arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of injection site pain.
This spontaneous report as received from a nurse refers to a 5 months 18 days old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Significant amount of blood on the Band-Aid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid). On 05-Feb-2021, VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid) had resolved.            No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable After second dose a gauze and then a band aid is placed on his arm.There was a significant amount of blood on the Band-Aid when he got up the next morning.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: TCR is attached on 24-June in which no new information.
admission 2/27/2022 Altered Mental Status and Weakness - Generalized, concerned that with his history of bone marrow transplant he is at greater risk for disseminated infection.      Admin Location (Facility) Health and Affiliates dose #3-09/23/2021-PFIZER